Table 2 Clinical characteristics of grouped serotypes
Serotype group | All patients | Fatal outcome | Any risk factor | Pneumonia | Meningitis | <2 years | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|
(all = 233) | (all = 233) | (all = 229) | (all = 229) | (all = 244) | |||||||
No | No(%) | P-value | No(%) | P-value | No(%) | P-value | No(%) | P-value | No(%) | P-value | |
Invasive | 59 | 8 (14%) | ns | 25 (46.3%) | 0.002 | 40 (75.5%) | <0.001 | 8 (15%) | ns (0.07) | 5 (9%) | ns (0.07) |
Pediatric | 91 | 20 (23%) | ns | 53 (60.2%) | ns | 30 (35.3%) | 0.039 | 29 (34%) | 0.03 | 26 (29%) | <0.001 |
PCV10 | 128 | 23 (19%) | ns | 68 (55.7%) | 0.003 | 65 (54.6%) | 0.001 | 28 (24%) | ns | 27 (21%) | ns |
PCV13 | 157 | 32 (21%) | ns | 87 (58.0%) | 0.004 | 76 (51.7%) | 0.004 | 31 (21%) | ns (0.06) | 29 (19%) | ns |
All serotypes | 244 | 49 (21%) | 151 (64.8%) | 102 (44.5%) | 58 (25%) | 41 (17%) | |||||